Contract sterilization services are projected to account for 78% of the sterilization services market by 2030.

The Business Research Company’s Contract sterilization services Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035

LONDON, GREATER LONDON , UNITED KINGDOM, October 16, 2026 /EINPresswire.com/ — The sterilization services sector is experiencing notable growth as healthcare providers and manufacturers increasingly rely on specialized processes to ensure safety and compliance. This overview explores the market’s size, key drivers, segments, major players, and emerging trends, shedding light on the evolving landscape through 2030.

Projected Expansion and Market Size of Sterilization Services
Sterilization services are set to surpass $8 billion by 2030, representing a significant portion of the broader Medical Laboratory Services market, which is forecasted to reach around $237 billion in the same year. Within the massive Healthcare Services industry, expected to be valued at $11,335 billion by 2030, sterilization services will contribute nearly 0.1% of the total. The market is anticipated to expand at a strong compound annual growth rate (CAGR) of 8% through the forecast period.

Request A Free Sample Of The Sterilization Services Market Report
https://thebusinessresearchcompany.com/sample_request?id=48089163&type=smp&name=Sterilization%20Services%20Market%20Report%202026&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Oct_PR

North America’s Dominance in Sterilization Services
By 2030, North America will hold the largest share of the sterilization services market, estimated at $3.5 billion, growing from $2.5 billion in 2025 at a CAGR of 7%. This growth is driven by increased outsourcing of sterilization by medical device and pharmaceutical companies, widespread adoption of single-use medical products, stringent regulatory requirements focused on sterility assurance, and investments in advanced sterilization infrastructure. The well-established healthcare and life sciences sectors in the U.S. and Canada underpin this robust expansion.

The United States Leads Regional Growth
Within North America, the United States will be the biggest national market for sterilization services, projected to reach $3.2 billion in 2030, up from $2.3 billion in 2025 at a 7% CAGR. This rise is supported by the manufacturing of complex medical devices that require specialized sterilization methods, a growing preference among healthcare producers to outsource sterilization functions, rigorous regulatory compliance demands, expanding pharmaceutical and biotech research activities, and the modernization of healthcare facilities relying heavily on dependable sterilization services.

Access The Detailed Sterilization Services Market Report Here
https://thebusinessresearchcompany.com/report/sterilization-services-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Oct_PR

Infection Control and Equipment Innovations Propel Market Growth
One of the primary factors accelerating market growth is the increasing prevalence of hospital-acquired infections. Healthcare providers are prioritizing infection prevention measures to enhance patient outcomes and reduce costs associated with healthcare-associated infections. A rise in surgical procedures, hospital admissions, and awareness of contamination risks is generating higher demand for reliable sterilization services and stricter protocols. This trend is expected to contribute roughly 2.3% to annual market growth.

The expanding medical device reprocessing industry also plays a crucial role. Hospitals are adopting more reprocessed medical devices to cut costs and promote environmental sustainability. Since these reusable instruments require validated sterilization before reuse, this creates strong demand for specialized sterilization providers, projected to add around 2.1% growth annually.

Technological advancements in sterilization equipment further drive market momentum. New technologies enhance efficiency, ensure consistent sterilization cycles, and improve compatibility with sensitive products. Better monitoring, automation, and process controls increase reliability and throughput for healthcare and life sciences organizations. This innovation is forecasted to add approximately 1.9% annual growth.

Validation and Contract Sterilization Services Generate Major Market Value
Among service types, sterilization validation and contract sterilization services offer the largest growth opportunities. Together, they are expected to add over $3 billion in market value by 2030. Contract sterilization alone is projected to expand by $2 billion from 2025 to 2030, while validation services will contribute an additional $1 billion. This growth reflects mounting regulatory scrutiny around sterility assurance, increased outsourcing by healthcare manufacturers, production of complex devices, and a heightened need for documented quality and compliance support throughout healthcare supply chains.

Contract Sterilization Emerges as the Leading Market Segment
The sterilization services market is broadly divided into two segments: contract sterilization services and sterilization validation services. Contract sterilization will dominate in 2030, accounting for 78% of the total market or $6 billion. This segment’s expansion is fueled by manufacturers’ preference for outsourcing sterilization to experts, avoiding capital expenditure on in-house facilities, demand for scalable sterilization capacity, focus on efficiency and regulatory compliance, and the broader range of sterilization technologies offered by contract providers.

Market Segmentation Based on Method, Delivery, and End-User
The market categorizes sterilization services by method, including X-ray irradiation, ethylene oxide sterilization (ETO), gamma sterilization, electron beam (E-beam) sterilization, and steam sterilization. Delivery modes are split into on-site and off-site sterilization services. End users include hospitals and clinics, medical device companies, pharmaceutical and biotechnology firms, and other healthcare-related customers.

Rapid Biological Indicator Testing Accelerates Sterility Validation
Rapid biological indicator (BI) sterility testing is transforming the market by enabling faster validation processes, improving regulatory compliance, and streamlining product release. For example, in September 2025, Nelson Laboratories LLC introduced RapidCert, a rapid BI testing service that shortens incubation times from seven days to just 48 hours by using advanced microbiological methods and instrumentation. This innovation provides quicker, accurate, and compliant sterility confirmation for manufacturers.

Industry Fragmentation and Competitive Landscape
The sterilization services market shows moderate fragmentation, with the top 10 companies holding about 28% of the revenue share in 2024. Barriers to entry include strict healthcare safety regulations, validated sterilization protocols, rigorous quality assurance, and the critical need for reliable infection prevention in hospitals, pharmaceutical manufacturing, and medical device production. Market leaders maintain strong positions through diverse service portfolios, established partnerships in healthcare and life sciences, global service networks, and ongoing innovation. As demand for outsourced sterilization and compliant processing grows, companies are expected to pursue collaborations, increase capacity, and expand regional presence.

Leading Players Holding Market Shares in 2024
Key companies dominating the market in 2024 include:
– STERIS PLC with an 8% share
– Sotera Health Company at 7%
– Ecolab Inc. holding 6%
– Belimed AG also at 6%
– Advanced Sterilization Products contributing 0.4%
– E-BEAM Services Inc. with 0.2%
– SteriTek Inc. holding 0.2%
– Medistri SA with 0.2%
– MICROTROL Sterilisation Services Pvt. Ltd. at 0.1%
– BGS Beta-Gamma-Service GmbH & Co. KG also at 0.1%

Strategies Companies Employ to Maintain a Competitive Edge
To stay ahead, companies are focusing on advancing sterilization technologies that ensure safety and regulatory compliance. They are adopting innovative low-temperature and sophisticated sterilization methods to improve efficiency and infection control. Additionally, expanding sterilization infrastructure boosts capacity and geographic coverage. Integrating automation and monitoring systems enhances accuracy and quality assurance in service delivery.

STERIS PLC Maintains Market Leadership
STERIS PLC led global sterilization service sales in 2024 with an 8% market share, according to The Business Research Company. Its infection prevention and sterilization solutions division offers a range of technologies such as ethylene oxide, gamma irradiation, steam, and hydrogen peroxide sterilization. These services support hospitals, medical device manufacturers, pharmaceutical companies, and healthcare facilities in maintaining infection control and meeting regulatory standards.

Key Companies, Equipment Suppliers, and End Users Shaping the Market
The sterilization services sector includes major firms such as STERIS PLC, Sotera Health Company, Ecolab Inc., Belimed AG, Advanced Sterilization Products, E-BEAM Services Inc., SteriTek Inc., Medistri SA, MICROTROL Sterilisation Services Pvt. Ltd., and BGS Beta-Gamma-Service GmbH & Co. KG, among others.

Equipment manufacturers and raw material providers influential in the market encompass STERIS Corporation, 3M Company, Getinge AB, Advanced Sterilization Products Services Inc., Cantel Medical Corporation, Belimed AG, Matachana Group, Tuttnauer USA Company Limited, Steelco S.p.A., MMM Group GmbH, Andersen Products Inc., Sotera Health Company, Fedegari Autoclavi S.p.A., Bausch + Stroebel SE, Systec GmbH, De Lama S.p.A., Shinva Medical Instrument Co. Ltd., Hanil Scientific Inc., HOGENT Industrial Sterilization Systems, Stryker Corporation, Johnson & Johnson, Baxter International Inc., Medtronic Health Inc., and Olympus Corporation.

Wholesalers and distributors serving the market include McKesson Corporation, Medline Industries LP, Owens & Minor Inc., Henry Schein Inc., Patterson Companies Inc., Fisher Scientific International Inc., VWR International LLC, Avantor Inc., Thermo Fisher Scientific Distribution Group, DHL Supply Chain Healthcare, DB Schenker Healthcare Logistics, Kuehne + Nagel International AG, UPS Healthcare Logistics, FedEx Healthcare Solutions, Movianto GmbH, Uniphar Group plc, Azelis Group N.V., Nippon Express Holdings Inc., Sinopharm Group Co. Ltd., Shanghai Pharma Group Co. Ltd., Phoenix Healthcare Distribution Ltd., HealthTrust Supply Chain, AmerisourceBergen Distribution Solutions, and Cencora Inc.

Major healthcare end users constituting this market are institutions like Mayo Clinic, Cleveland Clinic, Johns Hopkins Hospital, Massachusetts General Hospital, Stanford Health Care, Mayo Clinic Laboratories, Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, HCA Healthcare Inc., Kaiser Permanente, Apollo Hospitals Enterprise Limited, Fortis Healthcare Limited, Narayana Health, AIIMS New Delhi, NHS England, Charité Universitätsmedizin Berlin, Singapore General Hospital, Ramsay Health Care Limited, Mount Sinai Health System, Ascension Health, Intermountain Health, Providence Health & Services, Banner Health, CommonSpirit Health, and Tenet Healthcare Corporation.

New analytical features added to our 2026 market reports:
• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. We have published over 30,000+ reports across 27 industries and 60+ geographies. Our research is powered by 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

We provide continuous and custom research services, offering a range of specialized packages tailored to your needs, including Market Entry Research Package, Competitor Tracking Package, Supplier & Distributor Package and much more.

Disclaimer: Please note that the findings, conclusions and recommendations that TBRC Business Research Pvt Ltd delivers are based on information gathered in good faith from both primary and secondary sources, whose accuracy we are not always in a position to guarantee. As such TBRC Business Research Pvt Ltd can accept no liability whatever for actions taken based on any information that may subsequently prove to be incorrect. Analysis and findings included in TBRC reports and presentations are our estimates, opinions and are not intended as statements of fact or investment guidance.

Contact Us:
The Business Research Company
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email: marketing@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company.

Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X

Media gallery